| Triazole tethered isatin-coumarin based molecular hybrids as novel antitubulin agents: Design, synthesis, biological investigation and docking studies H Singh, JV Singh, MK Gupta, AK Saxena, S Sharma, K Nepali, PMS Bedi Bioorganic & Medicinal Chemistry Letters 27, 3974–3979, 2017 | 112 | 2017 |
| Rational approaches, design strategies, structure activity relationship and mechanistic insights for therapeutic coumarin hybrids H Singh, JV Singh, K Bhagat, HK Gulati, M Sanduja, N Kumar, ... Bioorganic & medicinal chemistry 27 (16), 3477-3510, 2019 | 100 | 2019 |
| Triazole tethered C5-curcuminoid-coumarin based molecular hybrids as novel antitubulin agents: Design, synthesis, biological investigation and docking studies PMSB Harbinder Singh, Mandeep Kumar, Kunal Nepali, Manish K. Gupta, Ajit K ... European Journal of Medicinal Chemistry 116, 102-115, 2016 | 97 | 2016 |
| An updated patent review: xanthine oxidase inhibitors for the treatment of hyperuricemia and gout (2011-2015) R Ojha, J Singh, A Ojha, H Singh, S Sharma, K Nepali Expert opinion on therapeutic patents 27 (3), 311-345, 2017 | 92 | 2017 |
| Design, synthesis, antimicrobial evaluation, and molecular modeling studies of novel indolinedione–coumarin molecular hybrids K Bhagat, J Bhagat, MK Gupta, JV Singh, HK Gulati, A Singh, K Kaur, ... ACS omega 4 (5), 8720-8730, 2019 | 89 | 2019 |
| Monocarbonyl curcumin-based molecular hybrids as potent antibacterial agents A Singh, JV Singh, A Rana, K Bhagat, HK Gulati, R Kumar, R Salwan, ... ACS omega 4 (7), 11673-11684, 2019 | 79 | 2019 |
| Design Strategies, Structure Activity Relationship and Mechanistic Insights for Purines as Kinase Inhibitors KN Sahil Sharma a, Jagjeet Singh b, Ritu Ojha a, Harbinder Singh a, Manpreet ... European Journal of Medicinal Chemistry 112, 298-346, 2016 | 70 | 2016 |
| New coumarin-benzotriazole based hybrid molecules as inhibitors of acetylcholinesterase and amyloid aggregation A Singh, S Sharma, S Arora, S Attri, P Kaur, HK Gulati, K Bhagat, N Kumar, ... Bioorganic & Medicinal Chemistry Letters 30 (20), 127477, 2020 | 62 | 2020 |
| Synthesis and evaluation of naphthoflavones as a new class of non purine xanthine oxidase inhibitors H Singh, S Sharma, R Ojha, MK Gupta, K Nepali, PMS Bedi Bioorganic & Medicinal Chemistry Letters 24 (17), 4192-4197, 2014 | 57 | 2014 |
| Synthesis, screening and docking of fused pyrano [3, 2-d] pyrimidine derivatives as xanthine oxidase inhibitor M Kaur, A Kaur, S Mankotia, H Singh, A Singh, JV Singh, MK Gupta, ... European Journal of Medicinal Chemistry 131, 14-28, 2017 | 55 | 2017 |
| Uracil-coumarin based hybrid molecules as potent anti-cancer and anti-bacterial agents M Sanduja, J Gupta, H Singh, PP Pagare, A Rana Journal of Saudi Chemical Society 24 (2), 251-266, 2020 | 52 | 2020 |
| Xanthine oxidase inhibitors: patent landscape and clinical development (2015–2020) JV Singh, PMS Bedi, H Singh, S Sharma Expert Opinion on Therapeutic Patents 30 (10), 769-780, 2020 | 42 | 2020 |
| Benzoflavone derivatives as potent antihyperuricemic agents JV Singh, G Mal, G Kaur, MK Gupta, A Singh, K Nepali, H Singh, ... MedChemComm 10, 128-147, 2019 | 28 | 2019 |
| Chemotherapeutic potential of acridine analogs: an ample review H Singh, H Singh, S Sharma Heterocycles: an international journal for reviews and communications in …, 2015 | 28 | 2015 |
| Therapeutic potential of targeting the receptor for advanced glycation end products (RAGE) by small molecule inhibitors H Singh, DK Agrawal Drug development research 83 (6), 1257-1269, 2022 | 27 | 2022 |
| Novel series of triazole containing coumarin and isatin based hybrid molecules as acetylcholinesterase inhibitors K Bhagat, JV Singh, A Sharma, A Kaur, N Kumar, HK Gulati, A Singh, ... Journal of Molecular Structure 1245, 131085, 2021 | 26 | 2021 |
| Most recent strategies targeting estrogen receptor alpha for the treatment of breast cancer N Kumar, HK Gulati, A Sharma, S Heer, AK Jassal, L Arora, S Kaur, ... Molecular Diversity 25, 603-624, 2021 | 25 | 2021 |
| Multi-targeting anticancer agents: Rational approaches, synthetic routes and structure activity relationship H Singh, N Kinarivala, S Sharma Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal …, 2019 | 25 | 2019 |
| Thiazole-5-carboxylic acid derivatives as potent xanthine oxidase inhibitors: design, synthesis, in vitro evaluation, and molecular modeling studies G Kaur, JV Singh, MK Gupta, K Bhagat, HK Gulati, A Singh, PMS Bedi, ... Medicinal Chemistry Research 29, 83-93, 2020 | 24 | 2020 |
| Novel ligands and modulators of triggering receptor expressed on myeloid cells receptor family: 2015-2020 updates H Singh, V Rai, SK Nooti, DK Agrawal Expert opinion on therapeutic patents 31 (6), 549-561, 2021 | 23 | 2021 |
Sahil SharmaMemorial Sloan Kettering Cancer Center在 mskcc.org 的电子邮件经过验证
